COMMUNIQUÉS West-GlobeNewswire

Heald Partners with Thatch Marketplace to Bring First-of-its-Kind Diabetes Reversal Program to Employees
23/04/2026
ALPHARETTA, Ga., April 23, 2026 (GLOBE NEWSWIRE) -- Heald, a leader in digital-first diabetes reversal, today announced a new partnership with Thatch, the modern health benefits platform. Through this collaboration, [...]
H1 Launches Site Network Suite, the First AI-Powered Platform to Transform How Research Sites and Sponsors Engage on Clinical Trials
23/04/2026
H1’s Core AI Engine Helps Sponsors Find Sites More Efficiently and Determine Feasibility Faster, Bringing Process from Months to Weeks NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- H1 , the AI-powered platform that [...]
Neocis and Yomi® S Named Winner of the 2026 TAG Awards for MedTech in Robotic & Procedural Innovation
23/04/2026
MIAMI, April 23, 2026 (GLOBE NEWSWIRE) -- Neocis®, the company behind the first and only FDA-cleared robotic system for dental implant surgery, today announced that Yomi® S has been named a winner of the 2026 TAG Awards [...]
Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M
23/04/2026
- PRIDCor Therapeutics Granted Global Development and Commercialization License for IMC-1 and IMC-2 Assets for All Indications, including Fibromyalgia and Long-COVID - - Dogwood Granted a Tiered Royalty up to 15% on Net [...]
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
23/04/2026
Expect to report topline data from both studies mid-2026 SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage [...]
MAPS Celebrates 40 Years at a Defining Moment for Psychedelics
23/04/2026
Founded in April 1986 to advance psychedelic research and knowledge, MAPS has raised more than $150 million, supported 45 studies, and shaped the global policy and cultural landscape of psychedelics. As science, policy [...]
NEW YORK PLASTIC SURGICAL GROUP ANNOUNCES OPENING OF HARRISON, NY LOCATION
23/04/2026
Harrison, NY, April 23, 2026 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group (NYPS Group), one of the nation’s longest‑standing and most respected private academic plastic surgery practices, is proud to announce the [...]
Codexis to Report First Quarter 2026 Financial Results on May 7
23/04/2026
REDWOOD CITY, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it [...]
Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
23/04/2026
Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc.  (“Tilray”, “our”, “we” or the “Company”) (NASDAQ: TLRY; TSX: TLRY), a [...]
Ritedose, University of South Carolina Welcome Top European Business Students for Immersive Learning about Advanced Manufacturing
23/04/2026
Collaboration showcases the Ritedose Center of Excellence as a global hub for advanced manufacturing education. The Center of Excellence serves as a cornerstone of Ritedose’s broader commitment to workforce development [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
23/04/2026
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
CytoDyn to Host Investor Webcast
23/04/2026
VANCOUVER, Washington, April 23, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
23/04/2026
CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report [...]
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
23/04/2026
SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter [...]
SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026
23/04/2026
Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion FORT LAUDERDALE, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS [...]
RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting
23/04/2026
Accepted Abstract is a Sub-Study in RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial and Explores the TAMP™ Therapy Platform’s Potential to Increase Local Drug Potency and Reduce Systemic Exposure and Common Side [...]
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference
23/04/2026
PARAMUS, NJ, April 23, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company focused on developing disease-modifying therapies for rare, pediatric lysosomal storage [...]
Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress
23/04/2026
Nes-Ziona, Israel, April 23, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that it will present [...]
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026
23/04/2026
Non-cardiotoxic anthracycline demonstrates activity where traditional chemotherapies have historically failed, supporting potential expansion of Annamycin into a major unmet-need indication Significant tumor volume [...]

Pages